-
1
-
-
33845875966
-
Gut hormones and the regulation of energy homeostasis
-
Murphy KG, Bloom SR. Gut hormones and the regulation of energy homeostasis. Nature 2006; 444: 854-859.
-
(2006)
Nature
, vol.444
, pp. 854-859
-
-
Murphy, K.G.1
Bloom, S.R.2
-
2
-
-
78650903000
-
GIP and GLP-1, the two incretin hormones: similarities and differences
-
Seino Y, Fukushima M, Yabe D. GIP and GLP-1, the two incretin hormones: similarities and differences. J Diabetes Invest 2010; 1: 8-23.
-
(2010)
J Diabetes Invest
, vol.1
, pp. 8-23
-
-
Seino, Y.1
Fukushima, M.2
Yabe, D.3
-
3
-
-
34248223285
-
Biology of incretins: GLP-1 and GIP
-
Baggio LL, Drucker DJ. Biology of incretins: GLP-1 and GIP. Gastroenterology 2007; 132: 2131-2157.
-
(2007)
Gastroenterology
, vol.132
, pp. 2131-2157
-
-
Baggio, L.L.1
Drucker, D.J.2
-
4
-
-
35748957503
-
The physiology of glucagon-like peptide 1
-
Holst JJ. The physiology of glucagon-like peptide 1. Physiol Rev 2007; 87: 1409-1439.
-
(2007)
Physiol Rev
, vol.87
, pp. 1409-1439
-
-
Holst, J.J.1
-
5
-
-
68149161100
-
Mining incretin hormone pathways for novel therapies
-
Wideman RD, Kieffer TJ. Mining incretin hormone pathways for novel therapies. Trends Endocrinol Metab 2009; 20: 280-286.
-
(2009)
Trends Endocrinol Metab
, vol.20
, pp. 280-286
-
-
Wideman, R.D.1
Kieffer, T.J.2
-
6
-
-
67349176115
-
Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes
-
Ahren B. Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes. Nat Rev Drug Discov 2009; 8: 369-385.
-
(2009)
Nat Rev Drug Discov
, vol.8
, pp. 369-385
-
-
Ahren, B.1
-
7
-
-
34447267513
-
Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis
-
Amori RE, Lau J, Pittas AG. Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis. JAMA 2007; 298: 194-206.
-
(2007)
JAMA
, vol.298
, pp. 194-206
-
-
Amori, R.E.1
Lau, J.2
Pittas, A.G.3
-
8
-
-
77449094873
-
Incretin-based therapies: review of current clinical trial data
-
Peters A. Incretin-based therapies: review of current clinical trial data. Am J Med 2011; 123(Suppl): S28-S37.
-
(2011)
Am J Med
, vol.123
, Issue.SUPPL.
-
-
Peters, A.1
-
9
-
-
0025116147
-
Relationship between molecular structures of sugars and their ability to stimulate the release of glucagon-like peptide-1 from canine ileal loops
-
Shima K, Suda T, Nishimoto K, et al. Relationship between molecular structures of sugars and their ability to stimulate the release of glucagon-like peptide-1 from canine ileal loops. Acta Endocrinol 1990; 123: 464-470.
-
(1990)
Acta Endocrinol
, vol.123
, pp. 464-470
-
-
Shima, K.1
Suda, T.2
Nishimoto, K.3
-
10
-
-
79952310049
-
Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down?
-
Nauck MA, Vardarli I, Deacon CF, et al. Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down? Diabetologia 2011; 54: 10-18.
-
(2011)
Diabetologia
, vol.54
, pp. 10-18
-
-
Nauck, M.A.1
Vardarli, I.2
Deacon, C.F.3
-
11
-
-
79251476847
-
Report of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus
-
Seino Y, Nanjo K, Tajima N, et al. Report of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus. Diabetol Int 2010; 1: 2-20.
-
(2010)
Diabetol Int
, vol.1
, pp. 2-20
-
-
Seino, Y.1
Nanjo, K.2
Tajima, N.3
-
12
-
-
58149145568
-
Effect of a low-glycemic index or a high-cereal fiber diet on type 2 diabetes: a randomized trial
-
Jenkins DJ, Kendall CW, McKeown-Eyssen G, et al. Effect of a low-glycemic index or a high-cereal fiber diet on type 2 diabetes: a randomized trial. JAMA 2008; 300: 2742-2753.
-
(2008)
JAMA
, vol.300
, pp. 2742-2753
-
-
Jenkins, D.J.1
Kendall, C.W.2
McKeown-Eyssen, G.3
-
13
-
-
0030587445
-
Characterization of the cDNA and gene encoding human PDE3B, the cGIP1 isoform of the human cyclic GMP-inhibited cyclic nucleotide phosphodiesterase family
-
Miki T, Taira M, Hockman S, et al. Characterization of the cDNA and gene encoding human PDE3B, the cGIP1 isoform of the human cyclic GMP-inhibited cyclic nucleotide phosphodiesterase family. Genomics 1996; 36: 476-485.
-
(1996)
Genomics
, vol.36
, pp. 476-485
-
-
Miki, T.1
Taira, M.2
Hockman, S.3
-
14
-
-
84857216684
-
Comparison of incretin immunoassays with or without plasma extraction: incretin secretion in Japanese patients with type 2 diabetes
-
in press). doi: 10.1111/j.2040-1124.2011.00141.x
-
Yabe D, Watanabe K, Kuwata H, et al. Comparison of incretin immunoassays with or without plasma extraction: incretin secretion in Japanese patients with type 2 diabetes. J Diabetes Invest 2011; (in press). doi: 10.1111/j.2040-1124.2011.00141.x.
-
(2011)
J Diabetes Invest
-
-
Yabe, D.1
Watanabe, K.2
Kuwata, H.3
-
15
-
-
0019459685
-
Cephalic phase, reflex insulin secretion. Neuroanatomical and physiological characterization
-
Berthoud HR, Bereiter DA, Trimble ER, et al. Cephalic phase, reflex insulin secretion. Neuroanatomical and physiological characterization. Diabetologia 1981; 20(Suppl): 393-401.
-
(1981)
Diabetologia
, vol.20
, Issue.SUPPL.
, pp. 393-401
-
-
Berthoud, H.R.1
Bereiter, D.A.2
Trimble, E.R.3
-
16
-
-
4444293785
-
Acarbose lowers serum triglyceride and postprandial chylomicron levels in type 2 diabetes
-
Ogawa S, Takeuchi K, Ito S. Acarbose lowers serum triglyceride and postprandial chylomicron levels in type 2 diabetes. Diabetes Obes Metab 2004; 6: 384-390.
-
(2004)
Diabetes Obes Metab
, vol.6
, pp. 384-390
-
-
Ogawa, S.1
Takeuchi, K.2
Ito, S.3
-
17
-
-
0024422762
-
Effect of loss of first-phase insulin secretion on hepatic glucose production and tissue glucose disposal in humans
-
Luzi L, DeFronzo RA. Effect of loss of first-phase insulin secretion on hepatic glucose production and tissue glucose disposal in humans. Am J Physiol 1989; 257: E241-E246.
-
(1989)
Am J Physiol
, vol.257
-
-
Luzi, L.1
DeFronzo, R.A.2
-
18
-
-
0026602267
-
Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance
-
Mitrakou A, Kelley D, Mokan M, et al. Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance. N Engl J Med 1992; 326: 22-29.
-
(1992)
N Engl J Med
, vol.326
, pp. 22-29
-
-
Mitrakou, A.1
Kelley, D.2
Mokan, M.3
-
19
-
-
0029935830
-
Effects of a change in the pattern of insulin delivery on carbohydrate tolerance in diabetic and nondiabetic humans in the presence of differing degrees of insulin resistance
-
Basu A, Alzaid A, Dinneen S, et al. Effects of a change in the pattern of insulin delivery on carbohydrate tolerance in diabetic and nondiabetic humans in the presence of differing degrees of insulin resistance. J Clin Invest 1996; 97: 2351-2361.
-
(1996)
J Clin Invest
, vol.97
, pp. 2351-2361
-
-
Basu, A.1
Alzaid, A.2
Dinneen, S.3
-
20
-
-
0024216182
-
Physiological importance of deficiency in early prandial insulin secretion in non-insulin-dependent diabetes
-
Bruce DG, Chisholm DJ, Storlien LH, et al. Physiological importance of deficiency in early prandial insulin secretion in non-insulin-dependent diabetes. Diabetes 1988; 37: 736-744.
-
(1988)
Diabetes
, vol.37
, pp. 736-744
-
-
Bruce, D.G.1
Chisholm, D.J.2
Storlien, L.H.3
-
21
-
-
0019003702
-
Cephalic-phase insulin secretion in normal and pancreatic islet-transplanted rats
-
Berthoud HR, Trimble ER, Siegel EG, et al. Cephalic-phase insulin secretion in normal and pancreatic islet-transplanted rats. Am J Physiol 1980; 238: E336-E340.
-
(1980)
Am J Physiol
, vol.238
-
-
Berthoud, H.R.1
Trimble, E.R.2
Siegel, E.G.3
-
22
-
-
0001095690
-
Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients
-
Vilsboll T, Krarup T, Deacon CF, et al. Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients. Diabetes 2001; 50: 609-613.
-
(2001)
Diabetes
, vol.50
, pp. 609-613
-
-
Vilsboll, T.1
Krarup, T.2
Deacon, C.F.3
-
23
-
-
0037902984
-
Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus
-
Vilsboll T, Krarup T, Sonne J, et al. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus. J Clin Endocrinol Metab 2003; 88: 2706-2713.
-
(2003)
J Clin Endocrinol Metab
, vol.88
, pp. 2706-2713
-
-
Vilsboll, T.1
Krarup, T.2
Sonne, J.3
-
24
-
-
79953170013
-
Little enhancement of meal-induced glucagon-like peptide 1 secretion in Japanese: -comparisonof type 2 diabetes patients and healthy controls
-
Yabe D, Kurose A, Lee S, et al. Little enhancement of meal-induced glucagon-like peptide 1 secretion in Japanese: -comparisonof type 2 diabetes patients and healthy controls. J Diabetes Invest 2010; 1: 56-59.
-
(2010)
J Diabetes Invest
, vol.1
, pp. 56-59
-
-
Yabe, D.1
Kurose, A.2
Lee, S.3
-
25
-
-
0035839040
-
Mammalian sweet taste receptors
-
Nelson G, Hoon MA, Chandrashekar J, et al. Mammalian sweet taste receptors. Cell 2001; 106: 381-390.
-
(2001)
Cell
, vol.106
, pp. 381-390
-
-
Nelson, G.1
Hoon, M.A.2
Chandrashekar, J.3
-
26
-
-
77949531914
-
Molecular mechanism of the sweet taste enhancers
-
Zhang F, Klebansky B, Fine RM, et al. Molecular mechanism of the sweet taste enhancers. Proc Natl Acad Sci USA 2010; 107: 4752-4757.
-
(2010)
Proc Natl Acad Sci USA
, vol.107
, pp. 4752-4757
-
-
Zhang, F.1
Klebansky, B.2
Fine, R.M.3
-
27
-
-
33751084573
-
The receptors and cells for mammalian taste
-
Chandrashekar J, Hoon MA, Ryba NJ, et al. The receptors and cells for mammalian taste. Nature 2006; 444: 288-294.
-
(2006)
Nature
, vol.444
, pp. 288-294
-
-
Chandrashekar, J.1
Hoon, M.A.2
Ryba, N.J.3
-
28
-
-
35448986920
-
Gut-expressed gustducin and taste receptors regulate secretion of glucagon-like peptide-1
-
Jang HJ, Kokrashvili Z, Theodorakis MJ, et al. Gut-expressed gustducin and taste receptors regulate secretion of glucagon-like peptide-1. Proc Natl Acad Sci USA 2007; 104: 15069-15074.
-
(2007)
Proc Natl Acad Sci USA
, vol.104
, pp. 15069-15074
-
-
Jang, H.J.1
Kokrashvili, Z.2
Theodorakis, M.J.3
-
29
-
-
72249115786
-
Ingestion of diet soda before a glucose load augments glucagon-like peptide-1 secretion
-
Brown RJ, Walter M, Rother KI. Ingestion of diet soda before a glucose load augments glucagon-like peptide-1 secretion. Diabetes Care 2009; 32: 2184-2186.
-
(2009)
Diabetes Care
, vol.32
, pp. 2184-2186
-
-
Brown, R.J.1
Walter, M.2
Rother, K.I.3
-
30
-
-
65249129179
-
Sweet taste receptor expressed in pancreatic beta-cells activates the calcium and cyclic AMP signaling systems and stimulates insulin secretion
-
Nakagawa Y, Nagasawa M, Yamada S, et al. Sweet taste receptor expressed in pancreatic beta-cells activates the calcium and cyclic AMP signaling systems and stimulates insulin secretion. PLoS ONE 2009; 4: e5106.
-
(2009)
PLoS ONE
, vol.4
-
-
Nakagawa, Y.1
Nagasawa, M.2
Yamada, S.3
-
31
-
-
64749083079
-
Incretin release from gut is acutely enhanced by sugar but not by sweeteners in vivo
-
Fujita Y, Wideman RD, Speck M, et al. Incretin release from gut is acutely enhanced by sugar but not by sweeteners in vivo. Am J Physiol Endocrinol Metab 2009; 296: E473-E479.
-
(2009)
Am J Physiol Endocrinol Metab
, vol.296
-
-
Fujita, Y.1
Wideman, R.D.2
Speck, M.3
-
32
-
-
67149121867
-
Effect of the artificial sweetener, sucralose, on gastric emptying and incretin hormone release in healthy subjects
-
Ma J, Bellon M, Wishart JM, et al. Effect of the artificial sweetener, sucralose, on gastric emptying and incretin hormone release in healthy subjects. Am J Physiol Gastrointest Liver Physiol 2009; 296: G735-G739.
-
(2009)
Am J Physiol Gastrointest Liver Physiol
, vol.296
-
-
Ma, J.1
Bellon, M.2
Wishart, J.M.3
-
33
-
-
56449093424
-
Glucose sensing in L cells: a primary cell study
-
Reimann F, Habib AM, Tolhurst G, et al. Glucose sensing in L cells: a primary cell study. Cell Metab 2008; 8: 532-539.
-
(2008)
Cell Metab
, vol.8
, pp. 532-539
-
-
Reimann, F.1
Habib, A.M.2
Tolhurst, G.3
-
34
-
-
72249113386
-
Activation of sodium-glucose cotransporter 1 ameliorates hyperglycemia by mediating incretin secretion in mice
-
Moriya R, Shirakura T, Ito J, et al. Activation of sodium-glucose cotransporter 1 ameliorates hyperglycemia by mediating incretin secretion in mice. Am J Physiol Endocrinol Metab 2009; 297: E1358-E1365.
-
(2009)
Am J Physiol Endocrinol Metab
, vol.297
-
-
Moriya, R.1
Shirakura, T.2
Ito, J.3
-
35
-
-
77949273334
-
The glucagon-like peptide 1 receptor is essential for postprandial lipoprotein synthesis and secretion in hamsters and mice
-
Hsieh J, Longuet C, Baker CL, et al. The glucagon-like peptide 1 receptor is essential for postprandial lipoprotein synthesis and secretion in hamsters and mice. Diabetologia 2010; 53: 552-561.
-
(2010)
Diabetologia
, vol.53
, pp. 552-561
-
-
Hsieh, J.1
Longuet, C.2
Baker, C.L.3
-
36
-
-
34249902025
-
Dipeptidyl peptidase-4 inhibition and the treatment of type 2 diabetes: preclinical biology and mechanisms of action
-
Drucker DJ. Dipeptidyl peptidase-4 inhibition and the treatment of type 2 diabetes: preclinical biology and mechanisms of action. Diabetes Care 2007; 30: 1335-1343.
-
(2007)
Diabetes Care
, vol.30
, pp. 1335-1343
-
-
Drucker, D.J.1
|